Latest BRAIDWELL LP Stock Portfolio
$3.19Billion– No. of Holdings #58
BRAIDWELL LP Performance:
2024 Q2: -6.12%YTD: -1.52%2023: -6.08%
Performance for 2024 Q2 is -6.12%, and YTD is -1.52%, and 2023 is -6.08%.
About BRAIDWELL LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, BRAIDWELL LP reported an equity portfolio of $3.2 Billions as of 30 Jun, 2024.
The top stock holdings of BRAIDWELL LP are NBIX, , XENE. The fund has invested 3.3% of it's portfolio in NEUROCRINE BIOSCIENCES INC and 3.3% of portfolio in CG ONCOLOGY INC.
The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC (AVDL), KINIKSA PHARMACEUTICALS LTD (KNSA) and TOURMALINE BIO INC stocks. They significantly reduced their stock positions in CULLINAN THERAPEUTICS INC (CGEM), OUTSET MED INC (OM) and TRANSMEDICS GROUP INC (TMDX). BRAIDWELL LP opened new stock positions in EXACT SCIENCES CORP (EXAS), AVADEL PHARMACEUTICALS PLC and IMMUNOCORE HLDGS PLC (IMCR). The fund showed a lot of confidence in some stocks as they added substantially to SPYRE THERAPEUTICS INC (AGLE), INSPIRE MED SYS INC (INSP) and CG ONCOLOGY INC.
The top stock holdings of BRAIDWELL LP are NBIX, , XENE. The fund has invested 3.3% of it's portfolio in NEUROCRINE BIOSCIENCES INC and 3.3% of portfolio in CG ONCOLOGY INC.
The fund managers got completely rid off AVADEL PHARMACEUTICALS PLC (AVDL), KINIKSA PHARMACEUTICALS LTD (KNSA) and TOURMALINE BIO INC stocks. They significantly reduced their stock positions in CULLINAN THERAPEUTICS INC (CGEM), OUTSET MED INC (OM) and TRANSMEDICS GROUP INC (TMDX). BRAIDWELL LP opened new stock positions in EXACT SCIENCES CORP (EXAS), AVADEL PHARMACEUTICALS PLC and IMMUNOCORE HLDGS PLC (IMCR). The fund showed a lot of confidence in some stocks as they added substantially to SPYRE THERAPEUTICS INC (AGLE), INSPIRE MED SYS INC (INSP) and CG ONCOLOGY INC.
BRAIDWELL LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024
BRAIDWELL LP Annual Return Estimates Vs S&P 500
Our best estimate is that BRAIDWELL LP made a return of -6.12% in the last quarter. In trailing 12 months, it's portfolio return was -7.09%.
New Buys
| Ticker | $ Bought |
|---|---|
| dexcom inc | 81,211,400 |
| exact sciences corp | 48,235,900 |
| avadel pharmaceuticals plc | 40,754,900 |
| kiniksa pharmaceuticals intl | 38,428,500 |
| immunocore hldgs plc | 27,019,400 |
| akero therapeutics inc | 25,440,000 |
| apellis pharmaceuticals inc | 23,468,600 |
| alphatec hldgs inc | 22,936,700 |
New stocks bought by BRAIDWELL LP
Additions
| Ticker | % Inc. |
|---|---|
| spyre therapeutics inc | 388 |
| inspire med sys inc | 273 |
| cg oncology inc | 192 |
| harrow inc | 135 |
| repligen corp | 126 |
| iovance biotherapeutics inc | 122 |
| xenon pharmaceuticals inc | 95.76 |
| alphatec hldgs inc | 79.49 |
Additions to existing portfolio by BRAIDWELL LP
Reductions
| Ticker | % Reduced |
|---|---|
| cullinan therapeutics inc | -85.8 |
| outset med inc | -71.07 |
| transmedics group inc | -69.09 |
| 4d molecular therapeutics in | -64.9 |
| haemonetics corp mass | -46.51 |
| krystal biotech inc | -39.48 |
| vaxcyte inc | -33.35 |
| penumbra inc | -28.15 |
BRAIDWELL LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| exact sciences corp | -133,114,000 |
| karyopharm therapeutics inc | -35,793,200 |
| insmed inc | -69,429,100 |
| ironwood pharmaceuticals inc | -19,937,500 |
| dbv technologies s a | -5,927,170 |
| biocryst pharmaceuticals inc | -17,168,300 |
| avadel pharmaceuticals plc | -45,071,800 |
| kiniksa pharmaceuticals ltd | -27,478,300 |
BRAIDWELL LP got rid off the above stocks
Sector Distribution
BRAIDWELL LP has about 76.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 76.2 |
| Others | 23.3 |
Market Cap. Distribution
BRAIDWELL LP has about 16.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 33.2 |
| SMALL-CAP | 24.7 |
| UNALLOCATED | 24.7 |
| LARGE-CAP | 14.2 |
| MEGA-CAP | 2 |
| MICRO-CAP | 1.3 |
Stocks belong to which Index?
About 47.1% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 52.9 |
| RUSSELL 2000 | 39.4 |
| S&P 500 | 7.7 |
BRAIDWELL LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BRAIDWELL LP
BRAIDWELL LP has 58 stocks in it's portfolio. About 25.8% of the portfolio is in top 10 stocks. VKTX proved to be the most loss making stock for the portfolio. TMDX was the most profitable stock for BRAIDWELL LP last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADPT | adaptive biotechnologies cor | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 1.85 | 2,514,540 | 59,116,800 | added | 388 | ||
| AKRO | akero therapeutics inc | 0.80 | 1,084,400 | 25,440,000 | new | |||
| ALEC | alector inc | 0.34 | 2,380,700 | 10,808,400 | unchanged | 0.00 | ||
| ALGN | align technology inc | 2.08 | 275,207 | 66,443,200 | added | 62.6 | ||
| APLS | apellis pharmaceuticals inc | 0.74 | 611,800 | 23,468,600 | new | |||
| ARQT | arcutis biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARVN | arvinas inc | 0.43 | 517,230 | 13,768,700 | new | |||
| ATEC | alphatec hldgs inc | 1.77 | 58,217,000 | 56,550,700 | added | 79.49 | ||
| ATEC | alphatec hldgs inc | 0.72 | 2,194,900 | 22,936,700 | new | |||
| AVDL | avadel pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 4.48 | 140,838,000 | 142,966,000 | added | 3.68 | ||
| BBIO | bridgebio pharma inc | 1.64 | 65,594,000 | 52,268,800 | reduced | -2.53 | ||
| BBIO | bridgebio pharma inc | 0.28 | 345,571 | 8,753,310 | added | 0.22 | ||
| BCRX | biocryst pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CELC | celcuity inc | 0.26 | 516,643 | 8,462,610 | new | |||
| CGEM | cullinan therapeutics inc | 0.10 | 176,173 | 3,072,460 | reduced | -85.8 | ||
| CNMD | conmed corp | 0.14 | 5,000,000 | 4,477,570 | new | |||
| CSTL | castle biosciences inc | 0.28 | 416,100 | 9,058,500 | new | |||